- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Sunitinib, as a multi-target tyrosine kinase inhibitor, has a wide and dose-dependent spectrum of side effects, and clinical risk control needs...
The usage and dosage of Sunitinib should be adjusted according to the indications, and special attention should be paid to dosage adjustment an...
Tamoxifen, as a selective estrogen receptor modulator, commonly has side effects involving the endocrine system, blood system, and reproductive...
Tamoxifen is a selective estrogen receptor modulator, mainly used for the treatment and prevention of breast cancer. The following is an explan...
As a medication for treating interstitial cystitis, the standard dose of Elmiro is 300mg per day, taken in divided doses. Special populations n...
Elmiro is a medication used to treat interstitial cystitis/bladder pain syndrome, and its efficacy and discontinuation precautions need to be e...
Daprodustat, as an inhibitor of hypoxia inducible factor prolyl hydroxylase, is mainly used to treat renal anemia. Its side effects involve mul...
Daprodustat is an oral hypoxia inducible factor prolyl hydroxylase inhibitor (HIF-PHI) primarily used for the treatment of anemia associated wi...
Veozah, as a selective estrogen receptor degrader, is contraindicated for use in specific populations, drug interactions, and dietary restricti...
Veozah is a selective estrogen receptor degrading agent (SERD), which is mainly used to treat ER+/HER2 advanced breast cancer. It exerts anti-t...
